Novartis AG

Novartis AG is a global healthcare company that focuses on the research, development, and manufacturing of a wide range of pharmaceutical products. As a leading entity in the pharmaceutical industry, Novartis is dedicated to improving patient health worldwide through innovative medicines and therapies. The company operates through two primary business segments: Innovative Medicines and Sandoz, the latter being a pioneer in generic and biosimilar drugs. This dual focus enables Novartis to address diverse health challenges, from complex noncommunicable diseases to high-demand medical needs. Headquartered in Basel, Switzerland, Novartis has a significant impact on the healthcare sector by continuously investing in scientific research and technological advancements to deliver new treatment options. Its extensive portfolio covers oncology, immunology, neuroscience, ophthalmology, and cardiovascular health, reflecting its commitment to sustainable patient outcomes. Novartis also emphasizes digital transformation in healthcare, embracing new data technologies to drive efficiencies in clinical trials and patient care. Its role is pivotal in the pharmaceutical market, where it collaborates with global health organizations to enhance access to medicine and strengthen healthcare systems.